Glembatumumab vedotin is a novel approach in tumor therapy. This antibody-drug conjugate carefully recognizes an receptor expressed on various tumor cells, releasing an powerful anti-cancer agent. Early medical studies https://www.targetmol.com/compound/glembatumumab_vedotin